Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate.

Derin SevenlerXin NiuSandy DossantosMehmet TonerTim R CresseyRebecca D SandlinPaul K Drain

Published in: The Journal of antimicrobial chemotherapy (2022)

Our rapid semi-quantitative test can measure tenofovir concentrations relevant to both tenofovir alafenamide and tenofovir disoproxil fumarate adherence, which may support adherence-promoting interventions across a range of HIV care settings.

Keyphrases

antiretroviral therapy
physical activity
glycemic control
type diabetes
metabolic syndrome